ciprofloxacin has been researched along with Myocardial Infarction in 8 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Myocardial Infarction: NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).
| Excerpt | Relevance | Reference |
|---|---|---|
| " In conclusion, long-term administration of levofloxacin and ciprofloxacin produced deleterious effects on the ECG pattern of rats with/without AMI." | 5.46 | Cardiotoxic effect of levofloxacin and ciprofloxacin in rats with/without acute myocardial infarction: Impact on cardiac rhythm and cardiac expression of Kv4.3, Kv1.2 and Nav1.5 channels. ( Abdelrady, AM; Farag, NE; Fawzy, MS; Moustafa, YM; Zaitone, SA, 2017) |
| " In conclusion, long-term administration of levofloxacin and ciprofloxacin produced deleterious effects on the ECG pattern of rats with/without AMI." | 1.46 | Cardiotoxic effect of levofloxacin and ciprofloxacin in rats with/without acute myocardial infarction: Impact on cardiac rhythm and cardiac expression of Kv4.3, Kv1.2 and Nav1.5 channels. ( Abdelrady, AM; Farag, NE; Fawzy, MS; Moustafa, YM; Zaitone, SA, 2017) |
| "Ciprofloxacin 500 mg was administered every 24 hours by nasogastric tube." | 1.28 | Absorption of oral ciprofloxacin in a patient with cardiogenic shock. ( Nightingale, C; Sullivan, M; Ujhelyi, MR, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Park, CH | 1 |
| Lee, J | 1 |
| Jung, HY | 1 |
| Kim, MJ | 1 |
| Lim, SH | 1 |
| Yeo, HT | 1 |
| Choi, EC | 1 |
| Yoon, EJ | 1 |
| Kim, KW | 1 |
| Cha, JH | 1 |
| Kim, SH | 1 |
| Chang, DJ | 1 |
| Kwon, DY | 1 |
| Li, F | 1 |
| Suh, YG | 1 |
| Navarro-Navajas, A | 1 |
| Casallas, I | 1 |
| Isaza, D | 1 |
| Ortiz, P | 1 |
| Baracaldo-Santamaría, D | 1 |
| Calderon-Ospina, CA | 1 |
| Abdelrady, AM | 1 |
| Zaitone, SA | 1 |
| Farag, NE | 1 |
| Fawzy, MS | 1 |
| Moustafa, YM | 1 |
| Müderris, T | 1 |
| Ürkmez, FY | 1 |
| Küçüker, ŞA | 1 |
| Sağlam, MF | 1 |
| Yılmaz, GR | 1 |
| Güner, R | 1 |
| Güleşen, R | 1 |
| Açıkgöz, ZC | 1 |
| Almpanis, G | 1 |
| Siahos, S | 1 |
| Karogiannis, NC | 1 |
| Mazarakis, A | 1 |
| Niarchos, C | 1 |
| Kounis, GN | 1 |
| Kounis, NG | 1 |
| Le, UN | 1 |
| Kim, HS | 1 |
| Kwon, JS | 1 |
| Kim, MY | 1 |
| Nguyen, VH | 1 |
| Jiang, SN | 1 |
| Lee, BI | 1 |
| Hong, Y | 1 |
| Shin, MG | 1 |
| Rhee, JH | 1 |
| Bom, HS | 1 |
| Ahn, Y | 1 |
| Gambhir, SS | 1 |
| Choy, HE | 1 |
| Min, JJ | 1 |
| Scognamiglio, F | 1 |
| Corso, C | 1 |
| Madeo, D | 1 |
| Castaman, G | 1 |
| Visco, C | 1 |
| Borghero, C | 1 |
| Ruggeri, M | 1 |
| Rodeghiero, F | 1 |
| Ujhelyi, MR | 1 |
| Sullivan, M | 1 |
| Nightingale, C | 1 |
1 review available for ciprofloxacin and Myocardial Infarction
| Article | Year |
|---|---|
[Bacteremia caused by ciprofloxacin-resistant Salmonella serotype Kentucky: a case report and the review of literature].
Topics: Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Central Venous Catheters; Ciprofloxa | 2016 |
7 other studies available for ciprofloxacin and Myocardial Infarction
| Article | Year |
|---|---|
Identification, biological activity, and mechanism of the anti-ischemic quinolone analog.
Topics: Animals; Anti-Bacterial Agents; Brain Ischemia; Cell Line, Tumor; Cell Survival; Disease Models, Ani | 2007 |
Type III Kounis Syndrome Secondary to Ciprofloxacin-Induced Hypersensitivity.
Topics: Acute Coronary Syndrome; Aged; Ciprofloxacin; Humans; Hypersensitivity; Kounis Syndrome; Myocardial | 2022 |
Cardiotoxic effect of levofloxacin and ciprofloxacin in rats with/without acute myocardial infarction: Impact on cardiac rhythm and cardiac expression of Kv4.3, Kv1.2 and Nav1.5 channels.
Topics: Animals; Anti-Bacterial Agents; Cardiotoxins; Ciprofloxacin; Dose-Response Relationship, Drug; Elect | 2017 |
Kounis syndrome: two extraordinary cases.
Topics: Aged, 80 and over; Animals; Anti-Infective Agents; Ciprofloxacin; Coronary Vasospasm; Female; Fishes | 2011 |
Engineering and visualization of bacteria for targeting infarcted myocardium.
Topics: Animals; Arabinose; Blotting, Western; C-Reactive Protein; Ciprofloxacin; Disease Models, Animal; Dr | 2011 |
Flow cytometry in the diagnosis of drug-induced thrombocytopenia: two illustrative cases.
Topics: Abciximab; Angioplasty, Balloon, Coronary; Anti-Bacterial Agents; Antibodies, Monoclonal; Anticoagul | 2008 |
Absorption of oral ciprofloxacin in a patient with cardiogenic shock.
Topics: Ciprofloxacin; Heart Ventricles; Humans; Intestinal Absorption; Intubation, Gastrointestinal; Male; | 1991 |